Vectored immunoprophylaxis (VIP) injection triggers creation of antibodies that prevent malaria in 70 percent of mice
A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a potential new path toward the elusive goal of malaria immunization.
Mice injected with a virus genetically altered to help the rodents create an antibody designed to fight the malaria parasite produced high levels of the anti-malaria antibody. The approach, known as Vector immunoprophylaxis, or VIP, has shown promise in HIV studies. It had never before been tested with malaria, for which no licensed vaccine exists.
A report on the research appears online Aug. 11 in the Proceedings of the National Academy of Sciences (PNAS).
Malaria is one of the world’s deadliest infectious diseases, killing as many as 1 million people per year, the majority of them children in Africa. Malaria patients get the disease from infected mosquitoes. Of the four types of malaria that affect humans, the parasite Plasmodium falciparum is the most lethal, responsible for the majority of malaria cases. Antimalarial treatments and mosquito habitat modification have contributed to a decline in malaria mortality. But the number of cases remains high, and stemming them is a top global health priority.
In their study, researchers used a virus containing genes that were encoded to produce an antibody targeted to inhibit P. falciparum infection. Up to 70 percent of the mice injected with the VIP were protected from malaria-infected mosquito bites. In a subset of mice that produced higher levels of serum antibodies, the protection was 100 percent. The mice were tested a year after receiving a single injection of the virus and were shown to still produce high levels of the protective antibody.
The Latest on: Malaria vaccine
[google_news title=”” keyword=”Malaria vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Malaria vaccine
- mRNA malaria vaccine due for first clinical trialon May 16, 2024 at 10:10 pm
Mahidol University has inched closer to starting the world's first clinical trial of an mRNA vaccine against malaria.Already tested on mice during a past laboratory trial, the vaccine candidate will ...
- Next-Gen malaria jabs can achieve WHO strategic goalon May 15, 2024 at 4:21 am
Almost half of the world’s population is at risk of malaria infection with some 249 million people diagnosed with the disease in 2022 ...
- Key Considerations: Effective Vaccine Rollout and Uptake in Sierra Leoneon May 15, 2024 at 3:07 am
Sierra Leone received its first shipment of 550,000 malaria vaccines in December 2023, marking a milestone for public health in a country that sees over two million hospital visits for malaria ...
- Data arms Africa’s fight against malariaon May 14, 2024 at 3:16 am
In March, ministers of health from 11 countries with the highest malaria burden on the continent met in Yaoundé, Cameroon, and committed to accelerating malaria mortality reduction. They made a ...
- Malaria Vaccine: Why is it Taking so Long?on May 13, 2024 at 5:00 pm
Given this not very promising scenario why do we continue to believe that development of a malaria vaccine is possible? [9] There are several reasons to believe that malaria vaccine development ...
- Path to a zero malaria world: a new type of net could cut risk of the mosquito-borne disease by halfon May 13, 2024 at 5:00 pm
We track the journey of how the mosquito first gets infected and how it passes the disease on to a human being.
- Malaria Vaccine: Why is it Taking so Long?on May 13, 2024 at 5:00 pm
Vaccines against malaria have been the object of constant endeavor by the scientific community and pharmaceutical industries for over three decades, with little success so far. Hopes for ...
- Stakeholders meet to learn malaria vaccination experience from Ghanaon May 8, 2024 at 10:03 pm
AS part of efforts to support wider introduction and rollout of malaria vaccine, the World Health Organization (WHO), PATH and other partners convened stakeholders from other African countries to ...
- Ghana: Enhancing capacity for malaria vaccine introduction and rollout in Africa through experience sharingon May 8, 2024 at 11:40 am
In 2024, more than 20 countries in Africa are to introduce the vaccine into routine immunization, with Cameroon, Burkina Faso, Benin, Liberia and Sierra Leone already leading the way. The scale-up of ...
- An adjuvant made in yeast could lower vaccine cost and boost availabilityon May 8, 2024 at 9:57 am
Adjuvants make vaccines more effective, though one of the best is an expensive extract from the soap bark tree. To lower the cost and avoid the laborious extraction process from bark, synthetic ...
via Bing News